The serum levels of CA15-3, CA19-9 and CEA in BC and CRC, and TPSA in PCa patients (P<0.001) were significantly increased compared with those noted to healthy individuals (Table 1). This evidence concerns the gene CEACAM5 and posterior cortical atrophy.